Patents by Inventor Inga Reynisdottir

Inga Reynisdottir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human type II diabetes gene-slit-3 located on chromosome 5q35
    Publication number: 20060141462
    Abstract: Association of Type II diabetes and a locus on chromosome 5q35 is disclosed. In particular, the gene SLIT-3 with this locus is shown by linkage analysis to be a susceptibility gene for Type II diabetes. Pathway targeting for drug delivery and diagnosis applications in identifying those have Type II diabetes or at risk of developing Type II diabetes, in particular those that are non-obese are described.
    Type: Application
    Filed: October 31, 2003
    Publication date: June 29, 2006
    Inventors: Inga Reynisdottir, Jeffrey Gulcher, Struan Grant, Gudmar Thorleifsson
  • Human type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
    Publication number: 20050214780
    Abstract: Association of Type II diabetes and a locus on chromosome 5 is disclosed. In particular, the gene KChIP1 within this locus is shown by linkage analysis to be a susceptibility gene for Type II diabetes. Pathway targeting for drug delivery and diagnosis applications in identifying those who have Type II diabetes or are at risk of developing Type II diabetes, in particular those that are non-obese are described.
    Type: Application
    Filed: April 7, 2004
    Publication date: September 29, 2005
    Applicant: deCODE genetics ehf.
    Inventors: Inga Reynisdottir, Jeffrey Gulcher, Struan Grant, Gudmar Thorleifsson
  • Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
    Publication number: 20050196784
    Abstract: Association of Type II diabetes and a locus on chromosome 5 is disclosed. In particular, the gene KChIP1 within this locus is shown by linkage analysis to be a susceptibility gene for Type II diabetes. Pathway targeting for drug delivery and diagnosis applications in identifying those who have Type II diabetes or are at risk of developing Type II diabetes, in particular those that are non-obese are described.
    Type: Application
    Filed: January 5, 2005
    Publication date: September 8, 2005
    Applicant: deCODE genetics ehf.
    Inventors: Inga Reynisdottir, Jeffrey Gulcher, Struan Grant, Gudmar Thorleifsson